Page 133 - 《中国药房》2026年6期

[ 2 ] JALLEH R J，RAYNER C K，HAUSKEN T，et al. Gastro‐ a new tool to assess risk of bias in systematic reviews was
intestinal effects of GLP-1 receptor agonists：mechanisms， developed[J]. J Clin Epidemiol，2016，69：225-234.
management，and future directions[J]. Lancet Gastroen‐ [14] SCHÜNEMANN H J，BRENNAN S，AKL E A，et al. The
terol Hepatol，2024，9（10）：957-964. development methods of official GRADE articles and re‐
[ 3 ] 王婷，王萍，尚鑫，等 . 胰高血糖素样肽-1 受体激动剂降 quirements for claiming the use of GRADE：a statement
低血糖、减轻体重外的获益分析[J]. 中国新药与临床杂 by the GRADE guidance group[J]. J Clin Epidemiol，
志，2025，44（11）：830-836. 2023，159：79-84.
[ 4 ] USHAKUMARI D S，SLADEN R N. ASA consensus- [15] PIEPER D，ANTOINE S L，MATHES T，et al. Systematic
based guidance on preoperative management of patients review finds overlapping reviews were not mentioned in
on glucagon-like peptide-1 receptor agonists[J]. Anesthesi- every other overview[J]. J Clin Epidemiol，2014，67（4）：
ology，2024，140（2）：346-348. 368-375.
[ 5 ] HASHASH J G，THOMPSON C C，WANG A Y. AGA [16] ABDULRAHEEM A，ABUJABER B，AYERS L，et al.
rapid clinical practice update on the management of pa‐ Impact of GLP-1 receptor agonists on upper gastrointesti‐
tients taking GLP-1 receptor agonists prior to endoscopy： nal endoscopy：an updated systematic review and meta-
communication[J]. Clin Gastroenterol Hepatol，2024，22 analysis[J]. Surg Endosc，2025，39（8）：5135-5151.
（4）：705-707. [17] AHMED Z，IQBAL A，ARIF S F，et al. Bowel preparation
[ 6 ] LI X Y，JIN Y，FENG X Y，et al. Perioperative manage‐ quality in patients using glucagon-like peptide-1 agonists：
ment of patients on GLP-1 receptor agonists：risks，recom- a systematic review and meta-analysis[J]. Gastrointest En‐
mendations，and future directions：a narrative review[J]. J dosc，2026，103（2）：235-240.e5.
Clin Anesth，2025，104：111871. [18] BAIG M U，PIAZZA A，LAHOOTI A，et al. Glucagon-
[ 7 ] TARAR Z I，FAROOQ U，CHAUDHRY A，et al. Evi‐ like peptide-1 receptor agonist use and the risk of residual
dence report on the safety of gastrointestinal endoscopy in gastric contents and aspiration in patients undergoing GI
patients on glucagon-like peptide-1 receptor agonists：a endoscopy：a systematic review and a meta-analysis[J].
systematic review and meta-analysis[J]. Diagnostics， Gastrointest Endosc，2025，101（4）：762-771.e13.
2025，15（6）：770. [19] BERAN A，NAYFEH T，AKHRAS A，et al. Effect of
[ 8 ] FACCIORUSSO A，RAMAI D，DHAR J，et al. Effects of glucagon-like peptide-1 receptor agonists on bowel prepa‐
glucagon-like peptide-1 receptor agonists on upper gastro‐ ration for colonoscopy：a systematic review and meta-
intestinal endoscopy：a meta-analysis[J]. Clin Gastroen‐ analysis[J]. Am J Gastroenterol，2025，120（7）：1653-1656.
terol Hepatol，2025，23（5）：715-725.e3. [20] CHIU Y T，CHEN Y T，LEE F J，et al. The impact of
[ 9 ] SINGH S，RAHMAN S H，KHAN N，et al. Effects of glucagon-like peptide-1 receptor agonists on the quality in‐
glucagon-like peptide-1 receptor agonists on endoscopy dicators of colonoscopy：a systematic review and meta-
outcomes：systematic review and meta-analysis[J]. Gastro‐ analysis[J]. Dig Liver Dis，2025，57（7）：1386-1392.
intest Endosc，2025，101（2）：343-349.e5. [21] ELMATI P R，JAGIRDHAR G S K，QASBA R K，et al.
[10] AROMATARIS E，FERNANDEZ R，GODFREY C M， GLP-1 agonists and the risk of pulmonary aspiration
et al. Summarizing systematic reviews：methodological during elective upper endoscopy：a systematic review and
development，conduct and reporting of an umbrella review meta-analysis[J]. Open Respir Med J，2025，19：e187430-
approach[J]. Int J Evid Based Healthc，2015，13（3）： 64372550.
132-140. [22] TAN Y，ZHANG X，LV X H，et al. Glucagon-like peptide-
[11] PAGE M J，MOHER D，BOSSUYT P M，et al. PRISMA 1 receptor agonists increase the risk of residual gastric
2020 explanation and elaboration：updated guidance and content and pulmonary aspiration on upper endoscopy：a
exemplars for reporting systematic reviews[J]. BMJ， meta-analysis[J]. Dig Liver Dis，2025，57（7）：1377-1385.
2021，372：n160. [23] MILDER D A，MILDER T Y，LIANG S S，et al.
[12] SHEA B J，REEVES B C，WELLS G，et al. AMSTAR 2：a Glucagon-like peptide-1 receptor agonists：a narrative re‐
critical appraisal tool for systematic reviews that include view of clinical pharmacology and implications for peri-
randomised or non-randomised studies of healthcare inter‐ operative practice[J]. Anaesthesia，2024，79（7）：735-747.
ventions，or both[J]. BMJ，2017，358：j4008. （收稿日期：2025-11-10 修回日期：2026-03-05）
[13] WHITING P，SAVOVIĆ J，HIGGINS J P T，et al. ROBIS： （编辑：陈 宏）

中国药房 2026年第37卷第6期 China Pharmacy 2026 Vol. 37 No. 6 · 811 ·